<code id='9998B8DFA1'></code><style id='9998B8DFA1'></style>
    • <acronym id='9998B8DFA1'></acronym>
      <center id='9998B8DFA1'><center id='9998B8DFA1'><tfoot id='9998B8DFA1'></tfoot></center><abbr id='9998B8DFA1'><dir id='9998B8DFA1'><tfoot id='9998B8DFA1'></tfoot><noframes id='9998B8DFA1'>

    • <optgroup id='9998B8DFA1'><strike id='9998B8DFA1'><sup id='9998B8DFA1'></sup></strike><code id='9998B8DFA1'></code></optgroup>
        1. <b id='9998B8DFA1'><label id='9998B8DFA1'><select id='9998B8DFA1'><dt id='9998B8DFA1'><span id='9998B8DFA1'></span></dt></select></label></b><u id='9998B8DFA1'></u>
          <i id='9998B8DFA1'><strike id='9998B8DFA1'><tt id='9998B8DFA1'><pre id='9998B8DFA1'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:2824
          A mother protests against the high cost of insulin by bringing her child's ashes to Sanofi's office in Cambridge, Mass. Her daughter died of complications arising from type 1 diabetes after rationing her insulin. Hyacinth Empinado/STAT

          Some were faced with the choice of paying their rent or paying for insulin. A few saw their children die after they rationed the lifesaving medication.

          They were all part of a group of protesters stationed outside the Cambridge, Mass., office of insulin maker Sanofi on a recent morning, rallying against the rising price of the drug.

          advertisement

          “I’m demanding Sanofi to decrease the cost of insulin. It is a medication that all type 1 diabetics need to survive. And without it, they will die like my daughter did,” said Antroinette Worsham, of Cincinnati, founder of the nonprofit T1 Diabetes Journey.

          In April 2017, her daughter Antavia Lee-Worsham, who had type 1 diabetes, died at 22 after struggling to pay for insulin. She had aged out of an assistance program at 21 and would sometimes get insulin from her sister Antanique, who also has type 1 diabetes.

          Worsham, along with Nicole Smith-Holt and James Holt, brought the ashes of their children, in hopes of giving them to Sanofi executives. However, they were stopped by cops and were not allowed on Sanofi’s grounds.

          advertisement

          “Nobody would come down and face me,” said Smith-Holt, a financial aid specialist from Richfield, Minn. “Nobody would take his ashes … so it’s frustrating. It makes me very angry.”

          Related: Protesters take anger over insulin prices to drug makers, some bearing children’s ashes

          Her son, Alec Smith, died in June 2017 at the age of 26, weeks after aging out of her health insurance plan.

          According to a 2016 analysis, the estimated annual cost of insulin per patient nearly tripled over an 11-year stretch, from $231 in 2002 to $736 in 2013.

          Sanofi is among the nation’s largest insulin makers — several of which have hiked the prices of the drug in recent years.

          “The price gouging has become such a problem that insulin now costs more than my rent, and I have to choose,” said Myranda Pierce, a graduate student at Boston University School of Medicine who has type 1 diabetes.

          Newsletters

          Sign up for Daily Recap

          A roundup of STAT's top stories of the day.

          Please enter a valid email address. Privacy Policy

          Sanofi spokesman Nicolas Kressmann said in an email statement he shares “similar concerns” with the protesters. He encouraged people with diabetes who cannot afford their medication to call the company’s hotline at 888-847-4877.

          But Pierce said programs like those are not enough.

          “I shouldn’t have to go beg for my insulin. It should be affordable to me.”

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Adults seen as increasingly susceptible to measles
          Adults seen as increasingly susceptible to measles

          MikeReddyforSTATSimonMatthewsmadethreetripsthisspringtotheemergencyroomofhislocalhospitalinEastbourn

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Can sheer will power keep patients alive in their dying hours?

          ArmellaLeungforSTATMarjorieSeverancehadlived91years,fivemonths,andtwoweekswhen,ifyoubelievesuchthing